The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms (NCT07143019)
p48/64 MW HPC in Aneurysm Occlusion (PIANO): Prospective, Multicenter, Single-arm Clinical Trial to Determine Safety and Effectiveness of the Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms.
🩺 Plain-English Summary (8th-Grade Level)
To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC Flow Modulation Device in the treatment of wide-necked intracranial aneurysms.
Who can join: Review the eligibility criteria below.
Location: Barrow Neurological Institute — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (22 Sites)
- Barrow Neurological Institute — Phoenix, Arizona
- UCSF Medical Center — San Francisco, California
- University of Colorado Anschutz — Aurora, Colorado
- Swedish Medical Research Center — Englewood, Colorado
- Baptist Health Research Institute — Jacksonville, Florida
- Piedmont Atlanta Hospital — Atlanta, Georgia
- Northwestern Medicine — Chicago, Illinois
- Advocate Lutheran General Hospital — Park Ridge, Illinois
- University of Iowa — Iowa City, Iowa
- Tufts Medical Center — Boston, Massachusetts
- WashU Medicine — St Louis, Missouri
- UBNS — Buffalo, New York
- North Shore University Hospital - Northwell Health — Manhasset, New York
- NYU Langone Health — New York, New York
- NewYork-Presbyterian / Weill Cornell Medical Center — New York, New York
- Stony Brook University Hospital — Stony Brook, New York
- East Carolina University Health Medical Center — Greenville, North Carolina
- The University of Oklahoma — Oklahoma City, Oklahoma
- Oregon Health & Science University Hospital (OHSU) / Oregon Stroke Center — Portland, Oregon
- University of Pennsylvania — Philadelphia, Pennsylvania
- Vanderbilt University Medical Center — Nashville, Tennessee
- University of Washington - Harborview Medical Center — Seattle, Washington
📞 Contact the Study Coordinator
Phone: +353 91 740 100
Email: mairead.cleary@wallabyphenox.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Hemorrhagic Stroke clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.